Sandoz And Pear Announce US Launch Of ReSETO To Treat Opioid Use Disorder

Sandoz And Pear Announce US Launch Of ReSET-O To Treat Opioid Use Disorder

BASEL (dpa-AFX) - Sandoz Inc., a Novartis division, and Pear Therapeutics, Inc., announced the US commercial launch of reSET-O for patients with Opioid Use Disorder or OUD. reSET-O, cleared by the...

More From BioPortfolio on "Sandoz And Pear Announce US Launch Of ReSET-O To Treat Opioid Use Disorder"